SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 326.61 |
Enterprise Value ($M) | 246.68 |
Book Value ($M) | 255.37 |
Book Value / Share | 3.95 |
Price / Book | 1.28 |
NCAV ($M) | 254.28 |
NCAV / Share | 3.93 |
Price / NCAV | 1.28 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.35 |
Return on Assets (ROA) | -0.30 |
Return on Equity (ROE) | -0.31 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 22.39 |
Current Ratio | 22.39 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 267.43 |
Assets | 268.52 |
Liabilities | 13.15 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -102.56 |
Net Income | -90.21 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -67.39 |
Cash from Investing | -37.99 |
Cash from Financing | 41.95 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Point72 Asset Management, L.P. | 6.30 | ||
13G/A | Deep Track Capital, LP | 9.87 | 71.35 | |
13G/A | Fairmount Funds Management LLC | 9.90 | 25.86 | |
13G/A | Venrock Healthcare Capital Partners III, L.P. | 7.30 | 21.29 | |
13G/A | Suvretta Capital Management, Llc | 9.50 | 69.28 | |
13G/A | LAV Biosciences Fund V, L.P. | 4.70 | 0.00 | |
13G/A | Fmr Llc | 4.84 | -41.57 | |
13G | BlackRock Inc. | 5.50 | ||
13G | Integrated Core Strategies (us) Llc | 5.60 | ||
13G/A | FIL Ltd | 8.38 | ||
13G/A | Flynn James E | 0.00 | -100.00 | |
13G | Millennium Management Llc | 4.10 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
i UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
111,754 | 458,412 | 24.38 | |
197,595 | 271,163 | 72.87 | |
219,220 | 290,920 | 75.35 | |
132,197 | 154,116 | 85.78 | |
(click for more detail) |
Similar Companies | |
---|---|
TARS – Tarsus Pharmaceuticals, Inc. | TBIO – Telesis Bio, Inc. |
TECH – Bio-Techne Corporation | TLRY – Tilray Brands, Inc. |
TNYA – Tenaya Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io